文献速递脑血管病外科神经重症

破裂脑动脉瘤第四脑室出血的结局:主动清除血肿与预防迟发性脑缺血的影响

Outcome of Fourth Ventricular Hemorrhage in Ruptured Brain Aneurysms: Impact of Active Blood Clearance and Delayed Cerebral Ischemia Prevention.
PubMed 文献 · Neurosurgery · 2024-11-26

该研究回顾了817例连续入院的动脉瘤性蛛网膜下腔出血(aSAH)患者,采用第四脑室出血量表(FVH)评估第四脑室血量,分析其预后意义及主动清除血肿与预防迟发性脑缺血(ABCD)的影响。结果显示,第四脑室出血呈球样扩张(FVH 4级)是预后不良的强预测因素;引入ABCD后,FVH 4级患者预后显著改善,25%在aSAH后6个月达到功能独立。

要点

  • 第四脑室出血球样扩张(FVH 4级)是aSAH后预后不良的强预测因素。
  • 引入ABCD后,FVH 4级患者不良结局发生率从93%降至76%(P=.017)。
  • ABCD未增加脑室炎发生率(P=.836)。

核心结论

  • 第四脑室出血球样扩张(FVH 4级)是aSAH后预后不良的强预测因素。
  • 引入ABCD后,这些患者预后显著改善,25%在aSAH后6个月达到功能独立。

研究设计与样本

  • 回顾性分析817例连续入院的aSAH患者,入院时间2009年1月1日至2022年12月31日。
  • 采用第四脑室出血量表(FVH)评估第四脑室血量:1级(无或极少血),2级(部分填充),3级(完全填充/铸型),4级(球样扩张)。
  • 在ABCD引入(2015年10月)前后进行多因素分析评估不良结局发生率。
  • 随后进行1:1匹配配对分析,比较接受ABCD与匹配的接受标准治疗患者的具体结局。
  • 神经功能结局在6个月时评估(独立改良Rankin量表)。

主要发现

  • ABCD引入前,FVH 3级患者不良结局为31/41(76%;OR 4.4),FVH 4级为38/41(93%;OR 29.1)。
  • ABCD引入后,FVH 3级患者不良结局降至23/40(58%;P=.043;OR 1.3),FVH 4级降至31/41(76%;P=.017;OR 3.6)。
  • 匹配配对分析显示,接受ABCD的FVH 4级患者不良结局较标准治疗改善(64% vs 89%,P=.024),但FVH 1至3级患者未见改善。
  • 接受ABCD治疗的患者脑室炎发生率未见增加(P=.836)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Blood in the fourth ventricle is associated with poor outcomes in patients with aneurysmal subarachnoid hemorrhage (aSAH). We investigated (1) the prognostic significance of the amount of blood in the fourth ventricle and (2) the influence of active blood clearance and delayed cerebral ischemia prevention (ABCD). METHODS: We reviewed 817 consecutive aSAH patients admitted between January 1, 2009, and December 31, 2022, assessing blood amount in the fourth ventricle using a fourth ventricular hemorrhage scale (FVH): grade 1 (no or minimal blood), grade 2 (partially filled), grade 3 (completely filled/cast), and grade 4 (ballooning). Incidence of poor outcomes was evaluated using multivariate analysis before and after the introduction of ABCD (October 2015). Subsequently, a 1:1 matched-pairs analysis compared outcomes specifically between patients who underwent ABCD and matched controls receiving standard care. Neurological outcomes were evaluated at 6 months (independent modified Rankin scale). RESULTS: Before ABCD, poor outcomes occurred in 31/41 FVH grade 3 patients (76%; odds ratio (OR) 4.4) and in 38/41 FVH grade 4 patients (93%; OR 29.1). After ABCD, the incidence of poor outcomes decreased to 23/40 in FVH grade 3 patients (58%; P = .043; OR 1.3) and 31/41 in FVH grade 4 patients (76%; P = .017; OR: 3.6). The matched-pairs analysis also showed improvement in poor outcomes for FVH grade 4 patients who underwent ABCD compared with standard care (64% vs 89%, P = .024), but not for FVH grade 1 to 3 patients. No increase in the incidence of ventriculitis was seen in patients receiving ABCD treatment ( P = .836). CONCLUSION: Ballooning fourth ventricular hemorrhage (grade 4 FVH) is a powerful predictor of poor outcomes after aSAH. With the introduction of ABCD, the prognosis of these patients improved considerably and 25% reached functional independence 6 months after aSAH.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Overstijns M, Csók I, Watzlawick R, et al. Outcome of Fourth Ventricular Hemorrhage in Ruptured Brain Aneurysms: Impact of Active Blood Clearance and Delayed Cerebral Ischemia Prevention. Neurosurgery. 2024. PMID: 39589117. doi:10.1227/neu.0000000000003284

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。